M

MNPR

MNPR

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
7%Bearish
Buy/Sell Ratio0% buys
BearishBullish
MNPR Live QuoteReal-time
$70.29
$2.06(-2.85%)1M
Day Range$68.69 – $72.80
Open$71.30
Previous Close$70.75
Volume138.7K
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$476.34M
P/E Ratio (TTM)24.5
Forward P/ENaN
EPS (TTM)$-2.44
Price to Book3.8
Dividend Yield0.65%
Beta (Volatility)1.61
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $70.29 (27%)
Low: $50.07High: $124.82
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$130.17-13.2% upside

Insider Buys

1

$105K

Insider Sales

14

$43.09M

Total Volume

$43.20M

15 transactions

Net Activity

$42.99M

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
25CONFIDENCE

Sentiment Rating

Moderate Distribution

CEO Conviction Index

Liquidating / Profit Taking

Key Drivers

  • •Heavy distribution: sales represent 100% of total transaction value.
  • •CEO selling activity detected. Often driven by option expiration or diversification plans.
  • •CFO buying activity detected. Statistical studies show CFO purchases have high predictive power due to their direct visibility into balance sheet details.
  • •Significant liquidation: total sale value exceeds $10M.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
T
1

Tactic Pharma LLC

10%

0 buys2 sells

$36.17M total

R
2

Robinson Chandler

CEO

0 buys2 sells

$3.23M total

S
3

Starr Christopher M

Dir

0 buys2 sells

$1.33M total

T
4

Tsuchimoto Kim R

Dir

0 buys3 sells

$1.10M total

A
5

Anderson Raymond

Dir

0 buys3 sells

$918K total

Trading History
MNPR insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Nov 2, 2026

2 weeks ago

Anderson Raymond

Dir

Director
Sell3.1K$68.35$215K

Nov 2, 2026

2 weeks ago

Tsuchimoto Kim R

Dir

Director
Sell4.1K$70.92$290K

Oct 1, 2026

1 months ago

Starr Christopher M

Dir

Director
Sell8.4K$78.50$659K

Sep 24, 2026

1 months ago

Robinson Chandler

CEO

CEO
Sell29.1K$88.00$2.56M

Aug 26, 2026

2 months ago

Tsuchimoto Kim R

Dir

Director
Sell4.1K$111.39$456K

Aug 25, 2026

2 months ago

Anderson Raymond

Dir

Director
Sell3.1K$111.98$352K

Aug 25, 2026

2 months ago

Anderson Raymond

Dir

Director
Sell3.1K$111.77$351K

Aug 26, 2026

2 months ago

Rioux Patrice

Acting Chief Medical Officer

C-Level
Sell1$111.26$111

Dec 26, 2025

10 months ago

Vu Quan Anh

CFO

CFO
Buy1.5K$69.95$105K

Dec 18, 2025

11 months ago

Klausner Arthur J

Dir

Director
Sell5.1K$67.15$344K

Sep 24, 2025

14 months ago

Tactic Pharma LLC

10%

10% Owner
Sell550.2K$63.61$35.00M

Jul 14, 2025

16 months ago

Tsuchimoto Kim R

Dir

Director
Sell8.9K$40.00$356K

Jul 14, 2025

16 months ago

Starr Christopher M

Dir

Director
Sell16.8K$40.00$672K

Jul 14, 2025

16 months ago

Robinson Chandler

CEO

CEO
Sell16.8K$40.00$672K

Apr 2, 2025

19 months ago

Tactic Pharma LLC

10%

10% Owner
Sell33.3K$35.00$1.17M
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
MNPR Buy Conviction0%
Industry Rank#387 of 569
Volume Contribution0.3%
Total Industry Activity$16.52B

MNPR has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%. MNPR ranks #387 in insider activity out of 569 tracked companies in its industry.

Insider Trading Summary & Commentary
Automated executive transaction analysis for MNPR

Over the last 90 days, corporate insiders at MNPR (MNPR) engaged in a total of 15 transactions reported via SEC Form 4 filings. Among these, 1 were open-market purchases and 14 were sales. The total volume of insider trading reached $43.20M.

The net insider activity for MNPR shows a net selling bias of $42.99M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Tactic Pharma LLC (10%), who traded 550.2K shares valued at $35.00M on Sep 24, 2025.

Live Market News
Real-time market headlines for MNPR
No recent headlines found for MNPR.

FAQs About MNPR Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for MNPR.

Based on SEC Form 4 disclosures, the Insider Confidence Score for MNPR is currently 25/100, which reflects a moderate distribution bias. This calculation accounts for a total of 1 purchases and 14 sales by company executives over the last 90 days.

The CEO Conviction Index for MNPR is rated as "Liquidating / Profit Taking". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.